David Tamblyn

Research Interests

Translational Health Outcomes Epidemiology Health Economics Health Policy Public Health

Mr David Tamblyn

Lecturer

School of Public Health

Faculty of Health and Medical Sciences

Mr David Tamblyn is the Manager at Adelaide Health Technology Assessment (AHTA) in the School of Public Health, University of Adelaide. He has worked in the field of health technology assessment for over 10 years, and has experience evaluating pharmaceuticals, devices and medical services. He has been involved in HTA evaluations for both reimbursement and regulatory purposes, and in the development of national guidelines to inform the assessment of pharmaceuticals and medical services.Mr Tamblyn's qualifications include a Masters of Public Health, University of Adelaide and Bachelor of Health Sciences, University of Adelaide. Mr Tamblyn is a Deputy Editor for the International Journal of Technology Assessment in Health Care (IJTAHC), a committee member of the TGA Expert Advisory Panel on Breast Implant Associated Anaplastic Large Cell Lymphoma, a committee member of the South Australian Policy Advisory Committee for Technology (SAPACT), and a committee member of the South Australian Medicines Evaluation Panel (SAMEP).

Date Position Institution name
2022 - ongoing Lecturer University of Adelaide

Date Institution name Country Title
University of Adelaide Australia Bachelor
University of Adelaide Australia Masters

Year Citation
2025 Carter, D., HASSAN, M., Gao, Y., Choi, O., Tamblyn, D., & Merlin, T. (2025). Engaging stakeholders along health technology assessment pathways: A scoping review of international practice. International Journal of Technology Assessment in Health Care, 41(1), e69-1-e69-9.
DOI
2022 Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., . . . Molsen, E. (2022). Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. European Journal of Health Economics, 23(8), 1309-1317.
DOI Scopus20 Europe PMC13
2015 Leach, D. A., Need, E. F., Toivanen, R., Trotta, A. P., Palenthorpe, H. M., Tamblyn, D. J., . . . Buchanan, G. (2015). Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome [Oncotarget. 2015; 6:16135-16150]. Oncotarget, 6(34), 36923.
DOI Scopus3 WoS2 Europe PMC2
2015 Leach, D., Need, E., Toivanen, R., Trotta, A., Palenthorpe, H., Tamblyn, D., . . . Buchanan, G. (2015). Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome. Oncotarget, 6(18), 16135-16150.
DOI Scopus69 WoS61 Europe PMC60
2014 Merlin, T., Tamblyn, D., Ellery, B., & NAHTA Quality Assurance Group. (2014). What's in a name? developing definitions for common health technology assessment product types of the international network of agencies for health technology assessment (Inahta). International Journal of Technology Assessment in Health Care, 30(4), 430-437.
DOI Scopus34 WoS33 Europe PMC30
2011 Tamblyn, D., Chopra, S., Yu, C., Kattan, M., Pinnock, C., & Kopsaftis, T. (2011). Comparative analysis of three risk assessment tools in Australian patients with prostate cancer. BJU International, 108(Suppl 2), 51-57.
DOI Scopus18 WoS17 Europe PMC13
2009 Beckmann, K., Pinnock, C., Tamblyn, D., Kopsaftis, T., Stapleton, A., & Roder, D. (2009). Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort. Asia Pacific Journal of Clinical Oncology, 2009(5), 247-256.
DOI Scopus12 WoS11
2008 Stapleton, A., Johns, R., Kopsaftis, T., & Tamblyn, D. (2008). Abnormal PSA tests: delays in referral. Australian Family Physician, 37(1-2), 84-88.
Scopus8 WoS8 Europe PMC3

Year Citation
2009 Beckmann, K., Pinnock, C. B., Tamblyn, D. J., Kopsaftis, T., Stapleton, A. M. F., & Roder, D. (2009). Prostate cancer in South Australia: equitable access but later presentation. In BJU INTERNATIONAL Vol. 103 (pp. 11-12). Gold Coast, AUSTRALIA: WILEY-BLACKWELL PUBLISHING, INC.

Year Citation
2015 Vogan, A., Mitchell, A., Tamblyn, D., & Merlin, T. (2015). Managed Entry Schemes: Enabling Access To Oncology Drugs Under Uncertainty. Poster session presented at the meeting of the 12th Annual Health Technology Assessment international (HTAi) Conference. Oslo, Norway.
2013 Moshi, M. R., Tamblyn, D., & Merlin, T. (2013). Rise of Co-dependent Technologies: Surveying Stakeholders’ about their opinion on the co-dependent technology framework and decision-making process [Poster]. Poster session presented at the meeting of SA State Population Health Conference. Adelaide, South Australia.
2013 Merlin, T. L., Ellery, B., Juneja, V., & Tamblyn, D. (2013). What’s in a name? - Mapping the different HTA products of INAHTA members. Poster session presented at the meeting of the 10th Annual Meeting Health Technology Assessment international (HTAi). Seoul, South Korea.

Year Citation
2024 Laka, M., Carter, D., Gao, Y., Choi, O., Tamblyn, D., & Merlin, T. (2024). International health technology market approval, funding and assessment pathways (1). Canberra: Commonwealth of Australia.
2024 Tamblyn, D., Morona, J., Carter, D., Kessels, S., & Merlin, T. (2024). Clinical Evaluation Methods in HTA (4). Canberra: Commonwealth of Australia.
2024 Merlin, T., Laka, M., Carter, D., Gao, Y., Choi, Y. -S., Parsons, J., . . . Tamblyn, D. (2024). Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning. Canberra, ACT: Commonwealth of Australia.
DOI WoS12
2024 Parsons, J., Milverton, J., Ellery, B., Tamblyn, D., & Merlin, T. (2024). Horizon scanning and early assessment: Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (2). Canberra, ACT: Commonwealth of Australia.
2024 Newton, S., Hill, H., Tamblyn, D., & Merlin, T. (2024). HTA Methods: Determination of Population, Intervention, Comparator, and Outcome (PICO): Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (3). Canberra, ACT: Commonwealth of Australia.
2022 Kessels, S., Mittal, R., Newton, S., & Tamblyn, D. (2022). Review of different minimally invasive therapeutic approaches for the management of patients with benign prostatic hyperplasia (MSAC FFP review 1697). Canberra: Commonwealth of Australia.
2022 Milverton, J., Demir, M., Carter, D., Hill, H., Parsons, J., Tamblyn, D., & Vogan, A. (2022). Genetic testing for children with hearing impairment (MSAC Application 1680). Canberra: Commonwealth of Australia.
2020 Tamblyn, D., Vogan, A., Parsons, J., Schubert, C., Bellman, S., & Carter, D. (2020). Technical report to supplement clinical utility card for genetic testing for diagnosis of inheritable cardiomyopathies (MSAC Application 1599). Canberra: Commonwealth of Australia.
2020 Tamblyn, D., Vogan, A., Parsons, J., Schubert, C., Bellman, S., & Carter, D. (2020). Clinical utility card for heritable cardiomyopathies.
2016 Tamblyn, D., Schubert, C., & Merlin, T. L. (2016). Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee, Version 5.0. Commonwealth of Australia.
2012 Morona, J. K., Newton, S., Wang, S., Tamblyn, D., Ellery, B., & Merlin, T. (2012). Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome (MSAC Application number 1153,). Canberra, ACT.: Commonwealth of Australia.

Year Citation
2015 Authors: Morona J, Tamblyn D, Ellery B, Merlin T. Title: National Evidence-Based Guideline on Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes. Description: N/A. Extent: N/A.
2011 Authors: Fitridge R, Templeton S, Buckley E, Docter S, Morona J, Reddin E, Juneja V, Merlin T. Title: National evidence-based guideline: Prevention, identification and mangement of foot complications in diabetes. Description: N/A. Extent: N/A.

Mr Tamblyn has taught into the University of Adelaide bachelor of medicine and surgery, and into both undergraduate and post-graduate public health. Topics covered include health economics, evaluation methods and epidemiology.

Date Institution Department Organisation Type Country
2021 - ongoing South Australian Medicines Evaluation Panel (SAMEP) SA Health Health services and related Australia
2018 - 2023 National Health and Medical Research Council National Health and Medical Research Council Health services and related Australia
2018 - ongoing South Australian Policy Advisory Committee on Technology (SAPACT) SA Health Health services and related Australia
2018 - ongoing TGA Expert Advisory Panel, Breast Implant Associated ALCL Therapeutics Goods Administration Health services and related Australia
2017 - ongoing International Journal for Technology Assessment in Health Care Editors Scientific research United Kingdom

Date Topic Presented at Institution Country
2017 - 2017 Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Evaluator Workshop Canberra AHTA, presenting at request of Australian Government Department of Health Australia
2016 - 2016 Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Review Submission Sponsor Workshop Sydney (3), Melbourne (2) AHTA, presenting at request of Australian Government Department of Health Australia

Connect With Me

External Profiles

Other Links